Med. praxi. 2024;21(1):47-52 | DOI: 10.36290/med.2023.045

The significance of highly dangerous infections in the context of potential biological weapons

MUDr. Eva Pernicová, MBA
Ústav veřejného zdraví LF Masarykovy univerzity, Brno
Centra očkování a cestovní medicíny Avenier, a. s.

Highly dangerous infections (HDIs) represent a heterogeneous group of infectious diseases. The common feature is the safety hazard they pose to human society if accidentally or intentionally disseminated. Diseases classified as HDIs may either have a severe clinical course and a high mortality rate or be highly infectious and easily transmissible among susceptible individuals. Some HDIs fulfill both conditions. The aim of the following text is to provide an overview of the most significant HDIs, highlight the potential threat as biological weapons, and present measures designed to reduce these risks or the consequences of such an attack.

Keywords: highly dangerous infections, contagiousness, biological weapons, biological safety levels, prevention.

Received: August 10, 2023; Revised: October 18, 2023; Accepted: November 15, 2023; Published: March 6, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pernicová E. The significance of highly dangerous infections in the context of potential biological weapons. Med. praxi. 2024;21(1):47-52. doi: 10.36290/med.2023.045.
Download citation

References

  1. Smetana J. Vysoce nebezpečné nákazy. První vydání. Praha: Mladá fronta; 2018.
  2. News and Terrosism, Communicating in a crisis [Internet]. National Academy of Sciences; 2004 [cited 2023 Jun 24]. Available from: https://www.dhs.gov/sites/default/files/publications/prep_biological_fact_sheet.pdf.
  3. Tin D, Sabeti P, Ciottone GR. Bioterrorism: An analysis of biological agents used in terrorist events. Am J Emerg Med. 2022 Apr;54:117-121. Go to original source... Go to PubMed...
  4. Janik E, Ceremuga M, Niemcewicz M, et al. Dangerous Pathogens as a Potential Problem for Public Health. Medicina (Mex). 2020 Nov 6;56(11):591. Go to original source... Go to PubMed...
  5. Bezek S, Jaung M, Mackey J. Emergency Triage of Highly Infectious Diseases and Bioterrorism. In: Hidalgo J, Woc­‑Colburn L, editors. Highly Infect Dis Crit Care [Internet]. Cham: Springer International Publishing; 2020 [cited 2023 Jun 24]. p. 23-36. Available from: http://link.springer.com/10.1007/978-3-030-33803-9_3. Go to original source...
  6. Beneš J. Infekční lékařství. Praha: Galén; 2009.
  7. Centers for Disease Control and Prevention, Health Topics A.Z [Internet]. 2022 [cited 2023 Jun 27]. Available from: https://www.cdc.gov/health­‑topics.html#cdc­‑atozlist.
  8. Center for Disease Control and Prevention, Facts About Ricin [Internet]. 2018 [cited 2023 Jun 27]. Available from: https://emergency.cdc.gov/agent/ricin/facts.asp.
  9. European Medicines Agency, List of Nationally Authorised Medicinal Products [Internet]. 2022 [cited 2023 Jul 20]. Available from: https://www.ema.europa.eu/en/documents/psusa/anthrax­‑vaccine­‑list­‑nationally­‑authorised­‑medicinal­‑products­‑psusa/00010771/202112_en.pdf.
  10. Center for Disease Control and Prevention, Maps and Statistics, Plague in the United States [Internet]. 2022. [cited 2023 Jul 20]. Available from: https://www.cdc.gov/plague/maps/index.html.
  11. Center for Disease Control and Prevention, Tularemia [Internet]. 2018 Apr 04 [cited 2023 Jul 25]. Available from: https://emergency.cdc.gov/agent/tularemia/facts.asp.
  12. Morse S, Henkel R. Francisella tularensis: Understanding Reported Occupational Exposures and Laboratory Methods Used for the Identification of Francisella tularensis. Appl Biosaf. 2018 Mar;23(1):11-18. Go to original source... Go to PubMed...
  13. Zhou D, Song H, Wang J, et al. Biosafety and biosecurity. J Biosaf Biosecurity. 2019 Mar;1(1):15-18. Go to original source... Go to PubMed...
  14. Department of Molecular Virology and Microbiology, SARS and MERS [Internet]. Baylor College of Medicine; 1998-2023 [cited 2023 Jul 28]. Available from: https://www.bcm.edu/departments/molecular­‑virology­‑and­‑microbiology/emerging­‑infections­‑and­‑biodefense/specific­‑agents/sars­‑mers.
  15. WHO, Ebola Virus Disease [Internet]. 2023 [cited 2023 Jun 26]. Available from: https://www.who.int/news­‑room/fact­‑sheets/detail/ebola­‑virus­‑disease?gclid=Cj0KCQjwqNqkBhDlARIsAFaxvwxWCFfZ­‑hZwn_uwd1zpMItLzzrF6oT­‑Z7V6dvgdhkKpQSFGOnpbBekaAuwpEALw_wcB.
  16. Hao R, Liu Y, Shen W, et al. Surveillance of emerging infectious diseases for biosecurity. Sci China Life Sci. 2022 Aug;65(8):1504-1516. Go to original source... Go to PubMed...
  17. Center of Disease Prevention and Control, Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations - United States, 2021 [Internet]. 2022 [cited 2023 Jun 28]. Available from: https://www.who.int/news­‑room/fact­‑sheets/detail/ebola­‑virus­‑disease?gclid=Cj0KCQjwqNqkBhDlARIsAFaxvwxWCFfZ­‑hZwn_uwd1zpMItLzzrF6oT­‑Z7V6dvgdhkKpQSFGOnpbBekaAuwpEALw_wcB.
  18. Volk KM, Gering TJ. Predicting Biosecurity Threats: Deployment and Detection of Biological Weapons. In: Trump BD, Florin MV, Perkins E, Linkov I, editors. Emerg Threats Synth Biol Biotechnol [Internet]. Dordrecht: Springer Netherlands; 2021 [cited 2023 Jun 18]. p. 195-207. Available from: https://link.springer.com/10.1007/978-94-024-2086-9_13. Go to original source...
  19. Bayot ML, King KC. Biohazard Levels. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Jun 17]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK535351/ PMID: 30570972.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.